Jolanta Gulbinovič

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries

Tomasz Bochenek, Vafa Abilova, Ali Alkan et al. · Frontiers in Pharmacology · 2018 · 111 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmaceutical Care +15

European countries with small populations can obtain low prices for drugs: Lithuania as a case history

Kristina Garuolienè, Brian Godman, Jolanta Gulbinovič et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2011 · 77 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

Brian Godman, Andrew Hill, Steven Simoens et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2021 · 73 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +17

Proposal for a regulation on health technology assessment in Europe – opinions of policy makers, payers and academics from the field of HTA

Patricia Vella Bonanno, Anna Bucsics, Steven Simoens et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2019 · 46 citations · Full text

Social Sciences, Health Law, Health Policy +13

Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Brian Godman, Andrew Hill, Steven Simoens et al. · Generics and Biosimilars Initiative Journal · 2019 · 45 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +17